It’s Like Bureaucrats Aren’t Medical Experts

Lysergic acid diethylamide (LSD), 3,4-Methylenedioxymethamphetamine (ecstacy), and psilocybin (magic mushrooms) are all categorized as Schedule I drugs, which means have no recognized medical use and dangerous to use even under medical supervision. However, as with cannabis, the scheduling of these drugs is being called into question because research is showing that they show a great deal of promise as medical treatments that are safe to use under medical supervision:

Psychedelic drugs like LSD and ecstasy ingredient MDMA have been shown to stimulate the growth of new branches and connections between brain cells which could help address conditions like depression and addiction.

Researchers in California have demonstrated these substances, banned as illicit drugs in many countries, are capable of rewiring parts of the brain in a way that lasts well beyond the drugs’ effects.

This means psychedelics could be the “next generation” of treatments for mental health disorders which could be more effective and safer than existing options, the study’s authors from the University of California.

It’s almost as if the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS), the departments tasked with deciding what drugs fall under what schedule, are composed primarily of bureaucrats who have little or no experience in experimental medicine.

Mind you, this groundbreaking research isn’t groundbreaking. Timothy Leary, a clinical psychologist, experimented with LSD and found that it had many promising medical uses. When he performed his initial experiments, LSD was legal. Experimentation, at least of the legal variety that can be published in journals, became a huge pain in the ass when the drug was listed as a Schedule I. Fortunately, scientists have become more willing to jump through the hoops required to experiment with Schedule I substances, which is why research is now rediscovering the potential medical benefits of LSD and other Schedule I substances. Unfortunately, just because medical scientists have demonstrated that a Schedule I substance actually has potential medical uses doesn’t mean that the bureaucrats in the DEA and HHS are going to change the substance’s scheduling. We know this because cannabis, which has been shown to have numerous medical uses and be perfectly safe to use, still remains a Schedule I substance.